[HTML][HTML] Guidelines for environmental infection control in health-care facilities
…, RYW Chinn, MJ Arduino, J Carpenter… - Morbidity and mortality …, 2003 - cdc.gov
The health-care facility environment is rarely implicated in disease transmission, except
among patients who are immunocompromised. Nonetheless, inadvertent exposures to …
among patients who are immunocompromised. Nonetheless, inadvertent exposures to …
The role of vitrification in anhydrobiosis
JH Crowe, JF Carpenter… - Annual review of …, 1998 - annualreviews.org
▪ Abstract Numerous organisms are capable of surviving more or less complete dehydration.
A common feature in their biochemistry is that they accumulate large amounts of …
A common feature in their biochemistry is that they accumulate large amounts of …
Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation
EY Chi, S Krishnan, TW Randolph… - Pharmaceutical …, 2003 - Springer
Irreversible protein aggregation is problematic in the biotechnology industry, where
aggregation is encountered throughout the lifetime of a therapeutic protein, including during …
aggregation is encountered throughout the lifetime of a therapeutic protein, including during …
The two micron all sky survey (2MASS)
MF Skrutskie, RM Cutri, R Stiening… - The Astronomical …, 2006 - iopscience.iop.org
Abstract Between 1997 June and 2001 February the Two Micron All Sky Survey (2MASS)
collected 25.4 Tbytes of raw imaging data covering 99.998% of the celestial sphere in the …
collected 25.4 Tbytes of raw imaging data covering 99.998% of the celestial sphere in the …
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
…, JPA Ioannidis, N Terrin, DR Jones, J Lau, J Carpenter… - Bmj, 2011 - bmj.com
Funnel plots, and tests for funnel plot asymmetry, have been widely used to examine bias in
the results of meta-analyses. Funnel plot asymmetry should not be equated with publication …
the results of meta-analyses. Funnel plot asymmetry should not be equated with publication …
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Non-randomised studies of the effects of interventions are critical to many areas of
healthcare evaluation, but their results may be biased. It is therefore important to understand …
healthcare evaluation, but their results may be biased. It is therefore important to understand …
[HTML][HTML] Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
Multiple imputation for missing data in epidemiological and clinical research: potential and
pitfalls | The BMJ Skip to main content Intended for healthcare professionals Access provided by …
pitfalls | The BMJ Skip to main content Intended for healthcare professionals Access provided by …
[PDF][PDF] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant …
…, JN Ingle, EA Perez, J Carpenter… - Journal of …, 2003 - mauriciolema.webhost4life.com
Purpose: Using a 2 2 factorial design, we studied the adjuvant chemotherapy of women with
axillary node–positive breast cancer to compare sequential doxorubicin (A), paclitaxel (T) …
axillary node–positive breast cancer to compare sequential doxorubicin (A), paclitaxel (T) …
Translocation as a species conservation tool: status and strategy
B Griffith, JM Scott, JW Carpenter, C Reed - Science, 1989 - science.org
Surveys of recent (1973 to 1986) intentional releases of native birds and mammals to the
wild in Australia, Canada, Hawaii, New Zealand, and the United States were conducted to …
wild in Australia, Canada, Hawaii, New Zealand, and the United States were conducted to …
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive …
IC Henderson, DA Berry, GD Demetri… - Journal of clinical …, 2003 - ascopubs.org
Purpose: This study was designed to determine whether increasing the dose of doxorubicin
in or adding paclitaxel to a standard adjuvant chemotherapy regimen for breast cancer …
in or adding paclitaxel to a standard adjuvant chemotherapy regimen for breast cancer …